New study aims to unlock secrets of heart transplant failure

NCT ID NCT03102125

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at why some transplanted hearts stop working well over time. Researchers will use heart MRI scans and advanced cell analysis to find early signs of trouble in 376 heart transplant patients. The goal is to better understand the causes of graft dysfunction so doctors can improve long-term survival for transplant recipients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Regadenoson (Lexiscan)

What this could lead to

If successful, this could help doctors detect early signs of heart transplant failure and improve how long transplanted hearts last.

What could go wrong

This is an observational study, not testing a new treatment. It may not lead to direct changes in patient care, and results may take years to apply.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT FAILURE AND REJECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Rejection, Psychology transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UC San Diego

    RECRUITING

    La Jolla, California, 92037, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••